Engineers Gate Manager’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$978K Sell
28,920
-20,208
-41% -$573K 0.01% 1066
2025
Q4
$1.34M Buy
+49,128
New +$1.72M 0.02% 892
2025
Q3
Sell
-16,548
Closed -$550K 2125
2025
Q2
$550K Sell
16,548
-6,169
-27% -$187K 0.01% 1432
2025
Q1
$666K Sell
22,717
-37,488
-62% -$1.24M 0.01% 1299
2024
Q4
$1.98M Buy
60,205
+36,192
+151% +$1.7M 0.03% 632
2024
Q3
$1.07M Sell
24,013
-1,793
-7% -$81.4K 0.02% 950
2024
Q2
$1.11M Sell
25,806
-10,764
-29% -$388K 0.03% 831
2024
Q1
$1.07M Buy
36,570
+11,984
+49% +$321K 0.03% 792
2023
Q4
$548K Buy
+24,586
New +$551K 0.02% 1127
2021
Q3
Sell
-16,603
Closed -$915K 1601
2021
Q2
$915K Sell
16,603
-231
-1% -$12.9K 0.06% 478
2021
Q1
$869K Buy
16,834
+9,934
+144% +$492K 0.04% 651
2020
Q4
$299K Sell
6,900
-9,198
-57% -$364K 0.01% 1296
2020
Q3
$563K Buy
16,098
+10,886
+209% +$477K 0.03% 928
2020
Q2
$279K Buy
+5,212
New +$241K 0.01% 1252
2020
Q1
Sell
-18,180
Closed -$868K 1532
2019
Q4
$868K Buy
18,180
+3,931
+28% +$149K 0.04% 716
2019
Q3
$462K Buy
+14,249
New +$590K 0.02% 820
2019
Q2
Sell
-4,100
Closed -$277K 1109
2019
Q1
$277K Buy
+4,100
New +$239K 0.02% 756

Other funds holding AGIO

Engineers Gate Manager's AGIO Position: Q1 2026 in Review

Engineers Gate Manager reduced its Agios Pharmaceuticals (AGIO) stake by 41% in Q1 2026, selling an estimated $573K and leaving 28,920 shares worth $978K. The position accounts for 0.01% of the portfolio, ranked #1066.

Engineers Gate Manager first reported a position in AGIO in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.98M in Q4 2024. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Engineers Gate Manager held 28,920 shares of Agios Pharmaceuticals worth $978K as of Q1 2026.
  • Engineers Gate Manager sold 20,208 Agios Pharmaceuticals shares in Q1 2026, an estimated $573K.
  • Agios Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1066 holding.
  • Engineers Gate Manager first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
  • Engineers Gate Manager's Agios Pharmaceuticals position peaked at $1.98M in Q4 2024.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.